APA (7th ed.) Citation

N, W., IM, O., A, N., A, C., C, B., H, M., . . . Furukawa, T. A. (2010). Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: Systematic review and meta-analysis. CNS Drugs, 24(1), 35. https://doi.org/10.2165/11319480-000000000-00000

Chicago Style (17th ed.) Citation

N, Watanabe, et al. "Safety Reporting and Adverse-event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-phase Treatment of Adults with Depression: Systematic Review and Meta-analysis." CNS Drugs 24, no. 1 (2010): 35. https://doi.org/10.2165/11319480-000000000-00000.

MLA (9th ed.) Citation

N, Watanabe, et al. "Safety Reporting and Adverse-event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-phase Treatment of Adults with Depression: Systematic Review and Meta-analysis." CNS Drugs, vol. 24, no. 1, 2010, p. 35, https://doi.org/10.2165/11319480-000000000-00000.